Banque Cantonale Vaudoise’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-1,667
| Closed | -$22K | – | 898 |
|
2024
Q2 | $22K | Hold |
1,667
| – | – | ﹤0.01% | 868 |
|
2024
Q1 | $38K | Hold |
1,667
| – | – | ﹤0.01% | 818 |
|
2023
Q4 | $22K | Buy |
1,667
+667
| +67% | +$8.8K | ﹤0.01% | 882 |
|
2023
Q3 | $20K | Hold |
1,000
| – | – | ﹤0.01% | 1062 |
|
2023
Q2 | $27K | Hold |
1,000
| – | – | ﹤0.01% | 1042 |
|
2023
Q1 | $58K | Buy |
1,000
+667
| +200% | +$38.7K | ﹤0.01% | 929 |
|
2022
Q4 | $17K | Hold |
333
| – | – | ﹤0.01% | 1072 |
|
2022
Q3 | $27K | Hold |
333
| – | – | ﹤0.01% | 1058 |
|
2022
Q2 | $23K | Hold |
333
| – | – | ﹤0.01% | 1101 |
|
2022
Q1 | $37K | Buy |
+333
| New | +$37K | ﹤0.01% | 1066 |
|
2021
Q4 | – | Sell |
-3,333
| Closed | -$291K | – | 1344 |
|
2021
Q3 | $291K | Buy |
+3,333
| New | +$291K | 0.01% | 710 |
|
2021
Q1 | – | Sell |
-1,333
| Closed | -$310K | – | 1151 |
|
2020
Q4 | $310K | Hold |
1,333
| – | – | 0.02% | 624 |
|
2020
Q3 | $292K | Buy |
+1,333
| New | +$292K | 0.02% | 578 |
|